AXGN · XBRL financial data

Axogen financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (AXGN's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue42,922*41,37847,91248,64449,405*48,56056,66260,08259,904*61,45769,73175,834
Cost of goods and services sold9,158*8,75812,56712,20611,830*13,62714,64414,08915,495*15,26819,05719,103
Gross profit33,764*32,62035,34536,43837,575*34,93342,01845,99344,409*46,18950,67456,731
Research and development7,301*7,4096,6586,9966,704*6,0916,8537,56512,376*7,5178,5898,950
General and administrative7,482*9,9569,41710,8348,830*9,4589,68910,83614,594*12,87113,41416,465
Operating income (loss)(3,194)*(4,560)(428)(316)2,017*(1,661)1,6721,912(9,772)*(2,832)(2,156)955
Interest expense1,843*2,3262,1851,8931,801*2,2501,9771,7571,718*69411
Other income (expense)(74)*(107)1(48)(46)*(37)179250*23(145)(51)
Income tax expense (benefit)year only0000*0000*000
Net income (loss)(3,893)*(6,635)(1,921)(1,858)450*(3,834)579708(13,156)*(19,584)(1,516)2,334
Earnings per share, basic USD per share(0.09)*(0.15)(0.04)(0.04)0.01*(0.08)0.010.02(0.28)*(0.38)(0.03)0.04
Earnings per share, diluted USD per share(0.09)*(0.15)(0.04)(0.04)0.01*(0.08)0.010.01(0.31)*(0.38)(0.03)0.04
Weighted average shares, basic thousands of shares43,052*43,23343,71343,88246,185*45,20446,06346,49546,421*51,59253,33955,158
Weighted average shares, diluted thousands of shares43,052*43,23343,71343,88246,185*45,20447,98149,08841,930*51,59253,33961,526

Balance sheet

CSV

Fiscal quarters (AXGN's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents31,02415,71319,18918,66227,55418,09620,03623,90235,54882,65494,572328,888
Short-term investments01,9211,9445,8685,9283,9739,88611,8895,98018,94716,84019,180
Accounts receivable25,14724,21225,15224,62924,10526,29528,02930,77526,16928,31334,12634,008
Inventory23,02027,63628,01529,36333,18335,50436,77440,58142,37346,07447,31349,063
Prepaid and other current assets2,8113,1811,9621,7302,4473,2022,6943,3096,3526,7205,5254,953
Total current assets88,00478,66382,26286,25299,21793,070103,419114,456120,422184,708200,376438,092
Right-of-use asset15,56215,24714,95214,88614,26513,90313,52713,13712,73214,28013,84513,394
Total assets196,827186,516188,932191,985203,728196,165205,453216,400221,687289,488304,863550,339
Accounts payable11,774———8,008———2,888———
Total current liabilities30,43022,93223,41523,03330,61021,74524,98028,00823,55626,01330,37436,456
Long-term debt46,60346,82547,04747,27247,49647,71647,93848,16248,387000
Lease liability, non-current21,12320,66320,21519,72019,19118,61218,01517,39316,83818,50018,07017,622
Total liabilities101,16293,36093,24592,57899,82190,80093,17795,59592,84044,68048,60654,236
Accumulated deficit(281,296)(287,931)(289,852)(291,710)(291,260)(295,094)(294,515)(293,807)(306,963)(326,547)(328,063)(325,729)
Total stockholders' equity95,66593,15695,68799,407103,907105,365112,276120,805128,847244,808256,257496,103
Total liabilities and equity196,827186,516188,932191,985203,728196,165205,453216,400221,687289,488304,863550,339
Common shares outstanding (cover page) thousands of shares43,20643,70543,83044,00844,34445,54446,01346,12251,89853,17853,76259,731

Cash flows

CSV

Fiscal quarters (AXGN's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(3,893)*(6,635)(1,921)(1,858)450*(3,834)579708(13,156)*(19,584)(1,516)2,334
Stock-based compensation1,327*3,9193,907*5,004*3,076*2,9095,168*5,424*16,611*6,8438,766*8,794*
Depreciation and amortization1,558*1,5201,657*1,654*1,636*1,7281,657*1,642*1,633*1,6041,607*1,576*
Net cash from operating activities(211)*(12,266)4,165*3,901*8,735*(13,179)7,730*3,223*3,038*1,5657,221*16,536*
Purchases of property and equipment1,463*924910*597*670*256722*1,520*1,247*2,789893*1,392*
Net cash from investing activities(277)*(3,251)(1,233)*(5,000)*(813)*1,339(6,947)*(3,751)*4,042*(15,964)500*(10,933)*
Proceeds from issuing common stock—————00*0*—134,0440*225,578*
Proceeds from long-term debtyear only———————————
Repayments of long-term debt—————00*0*—48,5850*0*
Net cash from financing activities418*204544*572*970*2,3821,157*2,394*4,566*59,5054,197*228,713*
Net change in cash(70)*(15,313)3,476*(527)*8,892*(9,458)1,940*1,866*11,646*45,10611,918*234,316*

Compare with peers

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Axogen328,88875,83416,536*59.7M— 10-QSep 30, 2026
Angiodynamics33,97380,915(15,330)42.1M2.2 quarters 10-QAug 31, 2026
Orthofix Medical103,810210,933(6,224)*40.7M16.7 quarters 10-QJun 30, 2026
Delcath Systems47,52129,1335,712*34.7M— 10-QJun 30, 2026
Ceribell41,98929,341(13,078)*38.8M7.8 quarters 10-QSep 30, 2026
Pulse Biosciences101,620434(18,709)*71.3M5.4 quarters 10-QJun 30, 2026
Iradimed63,28824,2036,997*12.8M— 10-QSep 30, 2026
Butterfly Network122,30132,598(2,266)*not reported10.3 quarters 10-QSep 30, 2026
Heartflow34,36264,082(8,577)*87.0M19.0 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.